Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia.

Vonk, Christian M; Al Hinai, Adil S A; Hanekamp, Diana; Valk, Peter J M

Vonk, Christian M; Al Hinai, Adil S A; Hanekamp, Diana; Valk, Peter J M.

Afiliação

Vonk CM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands.
Al Hinai ASA; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands.
Hanekamp D; National Genetic Center, Ministry of Health, Muscat 111, Oman.
Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands.

Cancers (Basel) ; 13(21)2021 Oct 29.

Article em En | MEDLINE | ID: mdl-34771594

Palavras-chave

MRD; acute myeloid leukemia; clonal hematopoiesis; minimal/measurable residual disease; next generation sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google